-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $12

Benzinga·08/11/2026 17:02:44
Listen to the news
Craig-Hallum analyst Adam Vogel initiates coverage on Alterity Therapeutics (NASDAQ:ATHE) with a Buy rating and announces Price Target of $12.